Q93009 (UBP7_HUMAN) Homo sapiens (Human)
Ubiquitin carboxyl-terminal hydrolase 7 UniProtKBInterProSTRINGInteractive Modelling
1102 aa; Sequence (Fasta) ; (Isoform 3)
Available Structures
71 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| USP7CD-UBL45 in complex with Ubiquitin |
Heteromer P0CG47; | 100 | ||||
| USP7CD-CTP in complex with Ubiquitin |
Heteromer P0CG47; | 100 | 1×CA; | |||
| Crystal structure of USP7/HAUSP in complex with ICP0 |
Heteromer P08393; | 100 | ||||
| Crystal structure of DNMT1 in complex with USP7 |
Heteromer P26358; | 100.0 | ||||
| Crystal Structure of human DNMT1 and USP7/HAUSP complex |
Heteromer P26358; | 100 | 2×ZN; | |||
| Crystal structure of USP7 in complex with DNMT1(K1115Q) |
Heteromer P26358; | 100.0 | 1×GOL; | |||
| Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquiti… |
Heteromer P0CG48; | 100 | ||||
| Crystal structure of USP7 ubiquitin-like domains in compact conformation |
Heteromer P08393; | 100.0 | 3×CL; | |||
| Crystal structure of USP7 catalytic domain [H294E] mutant in complex with ubiquitin |
Heteromer P0CG47; | 99.71 | 1×EPE; | |||
| Crystal structure of USP7 catalytic domain [L299A] mutant in complex with ubiquitin |
Heteromer P0CG47; | 99.71 | 2×GOL; | |||
| Crystal structure of USP7 catalytic domain [V302K] mutant in complex with ubiquitin |
Heteromer P0CG47; | 99.71 | ||||
| Crystal Structure of Ubl123 with an EZH2 peptide |
Heteromer Q15910; | 100 | ||||
| Crystal structure of USP7 ubiquitin-like domains in extended conformation |
Heteromer P08393; | 100 | 2×CL; | |||
| Crystal structure of USP7 catalytic domain [V302K] mutant in complex with ubiquitin (malonate bound) |
Heteromer P0CG47; | 99.71 | 1×MLA; 2×GOL; | |||
| Crystal structure of USP7 with RNF169 peptide |
Heteromer Q8NCN4; | 100.0 | ||||
| Crystal structure of USP7 in complex with UHRF1 |
Heteromer Q96T88; | 100.0 | ||||
| Structure of USP7 with a novel viral protein |
Heteromer F5HF68; | 100.0 | 1×GOL; | |||
| Structure of the vIRF4-HAUSP TRAF domain complex |
Heteromer Q2HR73; | 100 | ||||
| The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 364-367 |
Heteromer P04637; | 100.0 | ||||
| The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with an EBNA1 peptide |
Heteromer P03211; | 100.0 | 21×NA; | |||
| Crystal Structure Of USP7-NTD with MCM-BP |
Heteromer Q9BTE3; | 100.0 | ||||
| Crystal Structure of the USP7:HdmX(AHSS) complex |
Heteromer O15151; | 100.0 | ||||
| Crystal structure of usp7-ntd with an e2 enzyme |
Heteromer P51965; | 100.0 | ||||
| The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with mdm2 peptide 147-150 |
Heteromer Q00987; | 100.0 | ||||
| The Crystal Structure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 359-362 |
Heteromer P04637; | 100.0 | ||||
| Crystal Structure of the USP7:Hdm2(PSTS) complex |
Heteromer Q00987; | 100.0 | ||||
| Crystal structure of USP7 in complex with a 4-hydroxypiperidine based inhibitor | homo-2-mer | 100.0 | 3×SO4; 1×GOL; 2×CQ5; | |||
| Structure of DUB complex | homo-2-mer | 100.0 | 2×9QA; | |||
| High-resolution X-ray cocrystal structure of USP7 in complex with X4 | homo-2-mer | 100.0 | 2×DYO; | |||
| Structure of DUB complex | homo-2-mer | 100.0 | 2×9QD; 2×ACT; 1×GOL; | |||
| USP7 in complex with a novel inhibitor | homo-2-mer | 100.0 | 2×EZF; | |||
| structure of usp7 catalytic domain and three ubl-domains | monomer | 100.0 | ||||
| Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation | monomer | 100 | ||||
| Crystal structure of USP7 in complex with its inhibitor | monomer | 100.0 | 1×EIB; | |||
| Crystal structure of USP7-HUBL domain | monomer | 100 | ||||
| Mechanism of USP7 (HAUSP) activation by its C-terminal ubiquitin-like domain (HUBL) and allosteric … | monomer | 100 | 1×CL; | |||
| Crystal structure of HAUSP | monomer | 100.0 | ||||
| Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibit… | monomer | 100 | 1×SO4; 3×GOL; 1×8QQ; | |||
| Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibit… | monomer | 100.0 | 1×SO4; 1×GOL; 1×8RN; | |||
| USP7 IN COMPLEX WITH LIGAND COMPOUND 1 | monomer | 100.0 | 1×R4D; | |||
| USP7 IN COMPLEX WITH LIGAND COMPOUND 14 | monomer | 100.0 | 1×R4J; 1×ZN; | |||
| USP7 IN COMPLEX WITH LIGAND COMPOUND 18 | monomer | 100.0 | 1×R44; 1×ACT; | |||
| Crystal structure of the USP7/HAUSP catalytic domain | monomer | 100.0 | 4×BR; | |||
| The Crystal Structure of human USP7 USP domain from Biortus | monomer | 100.0 | 4×GOL; | |||
| Structure of the catalytic domain of USP7 (HAUSP) | monomer | 100.0 | ||||
| USP7 IN COMPLEX WITH LIGAND COMPOUND 7 | monomer | 100.0 | 1×R41; | |||
| Crystal structure of the USP7/HAUSP catalytic domain | monomer | 100.0 | 2×BR; | |||
| USP7 in complex with GNE6776 (6'-amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-c… | monomer | 100 | 1×8JP; | |||
| Crystal structure of USP7 in complex with the covalent inhibitor, FT827 | monomer | 100.0 | 1×8WN; 1×EDO; | |||
| USP7 in complex with Cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl)phenol) | monomer | 100.0 | 1×AJJ; 1×GOL; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 100.0 | 1×R4D; | |||
| Crystal structure of USP7 in complex with the non-covalent inhibitor, FT671 | monomer | 100.0 | 1×8WK; | |||
| USP7 IN COMPLEX WITH LIGAND COMPOUND 23 | monomer | 100.0 | 1×R3Y; | |||
| Structure of DUB complex | monomer | 100.0 | 1×9HS; 2×ZN; | |||
| Crystal structure of USP7 in complex with allosteric inhibitor FX1-3763 | monomer | 100.0 | 1×QBL; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 99.69 | 1×A1ICT; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 100.0 | 1×A1ICS; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 100.0 | 1×A1ICW; | |||
| USP7 in complex with GNE6640 (4-(2-amino-4-ethyl-5-(1H-indazol-5-yl)pyridin-3-yl)phenol) | monomer | 100.0 | 1×8JM; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 100.0 | 1×A1ICU; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 99.7 | 1×A1ICX; | |||
| Crystal structure of the apo-form of USP7 catalytic domain [V302K] mutant | monomer | 99.7 | 1×GOL; | |||
| High-resolution X-ray cocrystal structure of USP7 in complex with LX04-46 | monomer | 99.7 | 1×DVU; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 99.69 | 1×A1ICO; | |||
| Structure-guided discovery of selective USP7 inhibitors with in vivo activity | monomer | 100.0 | 1×A1ICV; | |||
| Crystal structure of the first two Ubl domains of Deubiquitylase USP7 | monomer | 100 | ||||
| Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a p53 peptide | monomer | 99.26 | ||||
| Crystal structure of the TRAF-like domain of HAUSP/USP7 | monomer | 100 | 2×CA; | |||
| Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a MDM2 peptide | monomer | 96.32 | ||||
| Crystal structure of the N-terminal domain of USP7/HAUSP. | monomer | 100.0 | ||||
| Solution NMR structure of human ubiquitin specific protease Usp7 UBL domain (residues 537-664). NES… | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5fwi.1.A | monomer | 0.82 | 100.00 | |||
| 4yoc.1.B | monomer | 0.82 | 100.00 | |||
| 2f1x.1.A | monomer | 0.74 | 96.18 | |||
| 5jtv.4.A | monomer | 0.57 | 98.79 | |||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 3 | 5fwi.1.A | monomer | 0.82 | 100.00 | |||
| Isoform 3 | 4yoc.1.B | monomer | 0.82 | 100.00 | |||
| Isoform 3 | 2f1x.1.A | monomer | 0.74 | 96.18 | |||
| Isoform 3 | 5jtv.4.A | monomer | 0.57 | 98.79 | |||
| Isoform 3 | 7yui.1.A | monomer | 0.50 | 12.36 | |||